[ad_1]
Highlight
- While everyone around the world is waiting for an antidote to the coronavirus, the bad news comes from the British pharmaceutical company AstraZeneca.
- They said they are voluntarily postponing clinical trials for their coronavirus for now.
- The decision was reportedly made after one of the volunteers who took part in the trial unexpectedly fell ill.
AstraZeneca is developing this antidote in collaboration with the University of Oxford. In the race to make the world’s corona vaccine, this antidote is at the top. A company spokesperson said: “An independent committee has decided to close the trial for the time being due to safety concerns during the global trial of the Oxford coronavirus ticker review.”
He added: “The trial has been suspended for the time being as a routine procedure due to an unexplained illness that occurred during the trial.” In the case of large trials, this disease can often occur, but it needs to be investigated, he said.
However, it is unknown at this time what he will do after leaving office.
It has been stopped abruptly during trial in several previous cases. However, this is the first time the Covid 19 Ticker Ticker test has been stopped.
Read the news in English
This time digital is now also in telegrams. Subscribe, stay updated. Just click here.
